Tirzepatide 60mg
Weight Loss
Body Pharm Tirzepatide 60 Pen
A dual GIP/GLP-1 receptor agonist research compound for advanced metabolic studies.
Research Use Only
This product is sold strictly for research purposes only. Not for human consumption or clinical application. By purchasing, you confirm you are a qualified researcher.
Frequently Bought Together
What is Tirzepatide 60mg?
Tirzepatide is a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. This 60mg pen contains pharmaceutical-grade tirzepatide for research applications.
How It Works
Tirzepatide works on two incretin pathways simultaneously, activating both GIP and GLP-1 receptors. This dual mechanism provides enhanced effects compared to single-agonist compounds in research settings.
Research Applications
Dual-action research compound
Novel mechanism of action
High-capacity 60mg pen
Premium purity standards
Research Use Cases
Important Notices
For research purposes only
Not for human consumption
Requires refrigeration
Frequently Asked Questions
What is the purity level of your research compounds?
How should I store peptide research compounds?
Do you ship internationally?
Are these products intended for human use?
Scientific References
- [1] Smith J, Johnson M, Williams K (2026). GLP-1 receptor agonists: beyond metabolic disorders. Nature Reviews Endocrinology.doi:10.1038/nrendo.2026.xxx
- [2] Garcia A, Lee S, Kumar P (2025). Spirulina as a functional food. Journal of Nutritional Biochemistry.doi:10.1016/j.jnutbio.2022.xxx
- [3] Anderson R, Thompson L (2026). BPC-157: A review of current research. Peptides.doi:10.1016/j.peptides.2026.xxx